|
| Read more ›› |
|
By: GlobenewsWire - 17 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 16 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 14 Nov 2020
|
|
|
BANGKOK, Nov. 12, 2020 /PRNewswire/ -- B. Braun Thailand won the coveted 'Best Companies to Work for in Asia 2020 Award' by HR Asia on 16(th) October 2020. Read more ›› |
|
By: PR Newswire Association LLC. - 12 Nov 2020
|
|
|
SEOUL, South Korea, Nov. 12, 2020 /PRNewswire/ -- Suh Kyungbae Science Foundation (Chairman Suh Kyungbae) held the SUHF Symposium 2020 at Amore Hall, Amorepacific HQ on November 7 (Saturday), 2020. Read more ›› |
|
By: PR Newswire Association LLC. - 12 Nov 2020
|
|
Related companies:
AmorePacific R&D Center |
AMOREPACIFIC Corporation |
AMOREPACIFIC Ventures |
|
|
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into in July 2019... Read more ›› |
|
By: PR Newswire Association LLC. - 09 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 06 Nov 2020
|
|
|
BRUSSELS, Nov. 5, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its TNF inhibitor, CIMZIA(® )(certolizumab pegol), and investigational IL-17A and IL-17F inhibitor, bimekizumab. Data are being presented at the American College of Rheumatology... Read more ›› |
|
By: PR Newswire Association LLC. - 06 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 05 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 03 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 03 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 03 Nov 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 02 Nov 2020
|
|
|
INCHEON, South Korea and SUZHOU, China, Nov. 1, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an antibody drug conjugate (ADC) for the treatment of non-small-cell lung carcinoma... Read more ›› |
|
By: PR Newswire Association LLC. - 02 Nov 2020
|
|
Related companies:
Samsung Biologics Co., Ltd. |
GeneQuantum Healthcare (Suzhou) Co., Ltd. |
|
|
BRUSSELS, Oct. 31, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A and IL-17F inhibitor bimekizumab achieved superior skin clearance,... Read more ›› |
|
By: PR Newswire Association LLC. - 31 Oct 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 30 Oct 2020
|
|
Related companies:
OliX Pharmaceuticals, Inc |
|
|
- Entering phase 2 clinical trial in the United States based on trial results in South Korea, India, and Australia Read more ›› |
|
By: PR Newswire Association LLC. - 30 Oct 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 30 Oct 2020
|
|
|
| Read more ›› |
|
By: GlobenewsWire - 29 Oct 2020
|
|
|
BRUSSELS, Oct. 29, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that new data on the investigational IL-17A and IL-17F inhibitor, bimekizumab, and TNF inhibitor, CIMZIA(® )(certolizumab pegol), in the management of moderate-to-severe plaque psoriasis are being... Read more ›› |
|
By: PR Newswire Association LLC. - 29 Oct 2020
|
|
|
|
|
|
Biotechgate Global Database ›
